Analyst
H.C. Wainwright
Equibles does not estimate personal net worth.
Dan Amfaram is recorded as Analyst at H.C. Wainwright. Dan Amfaram has spoken on 1 earnings call across 1 company, most recently for Assertio Holdings, Inc. on March 12, 2025. The companies whose calls Dan Amfaram spoke on are classified in the Healthcare sector.
“So regarding Indusyn, how many generics are there at this point in time, and how many are you expecting to be at the end of 2025 and 2026? And as a follow-up, regarding the Syntizan initial commercial sort of study, have there been any noteworthy changes on uptake there recently?”
H.C. Wainwright
Analyst
Transcript header (unverified)
Assertio Holdings, Inc.
Drug Manufacturers - Specialty & Generic · Healthcare
Assertio Holdings, Inc. Q4 FY2024 Earnings Call
Assertio Holdings, Inc.
